Related Experiment Videos
Stacking interactions of ApA analogues with modified backbones
H Kang1, P J Chou, W C Johnson
1Department of Biochemistry and Biophysics, Oregon State University, Corvallis 97331.
Biopolymers
|October 11, 1992
Summary
Modified oligonucleotides show potential as antisense agents. Uncharged backbones with morpholino sugar substitution enable strong base stacking, crucial for therapeutic applications.
Area of Science:
- Biochemistry
- Oligonucleotide Chemistry
- Antisense Therapeutics
Background:
- Oligonucleotides with modified backbones are investigated as antisense agents for viral therapeutics.
- Understanding base stacking interactions is crucial for designing effective oligonucleotide-based drugs.
Purpose of the Study:
- To investigate the base stacking behavior of ApA analogues with modified backbones.
- To determine the impact of backbone modifications on oligonucleotide structure and stability.
- To evaluate the potential of these modified oligonucleotides as antisense agents.
Main Methods:
- Circular Dichroism (CD) spectroscopy was used to measure spectra as a function of temperature.
- Singular value decomposition (SVD) was applied to analyze spectral data.
- Taylor series decomposition was employed to quantify base stacking interactions.
- The van't Hoff equation was utilized to calculate thermodynamic parameters.
Main Results:
- Oligonucleotides with uncharged backbones (carbonyl for phosphate) and sugar or morpholino substitution showed no base stacking.
- Morpholino group substitution for sugar, with an uncharged phosphate, resulted in strong base stacking.
- Phosphorus-linked morpholino analogues exhibited stacking interactions comparable to or stronger than d(ApA).
- CD spectral analysis indicated two-state stacking behavior.
Conclusions:
- Backbone modification significantly influences base stacking in oligonucleotides.
- Morpholino-phosphorus linkages promote robust base stacking, essential for antisense activity.
- These findings provide insights into the structural requirements for effective antisense oligonucleotide design.